secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hepion Pharmaceuticals, Inc. (HEPA)
CIK:        0001583771
Form:       8-K
Filed at:   2024-02-16T23:59:59+00:00
Accession:  0001104659-24-024738
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hepion raises $2.06M via warrant inducement, reduces exercise prices and issues new warrants
--------------------------------------------------------------------------------

- Holders of 980,393 Series B warrants will exercise at reduced price of $2.10/share, raising ~$2.06M gross proceeds.
- As inducement, Company reduces Series A warrant exercise price to $1.91 (from $4.85) and extends expiration to Feb 2029.
- Company issues new Series B-1 and B-2 warrants to purchase up to 735,295 shares each at $1.91.
- Engaged A.G.P./Alliance Global Partners as financial advisor; cash fee of 7% of gross proceeds.
- Net proceeds to be used for general working capital and corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583771/000110465924024738/0001104659-24-024738-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583771/000110465924024738/tm246503d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-024738

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer